Commercialisation Advice - IP and IT

Our relevant and notable experience includes:

• Acting for Coogee Chemicals in relation to commercialisation with CSIRO of novel industrial technology
• Acting for numerous software and IT related start-ups, advising on all legal aspects of their businesses and commercialisation strategies
• Acted for First Physio in relation to commercialisation of the Halo medical device- shareholder agreements, subscription agreements, IP assignment agreements, sale agreements
• Acting for GSS and GMapps in relation to IP ownership arrangements with respect to novel minerals exploration technology- shareholder agreements, subscription agreements, IP assignment agreements, etc
• Acting in a wide range of matters for clients involved in consumer products, agribusiness, wine and  processing relating to the commercialisation of intellectual property
• A Director of Williams + Hughes, Damian Quail, has served on the Board of Directors of several technology companies, including epiTactix, a CSIRO spinout developing novel gallium arsenide semiconductors, and IMapps, a developer of mobile phone apps